Todd Asset Management LLC Vertex Pharmaceuticals Inc Transaction History

Todd Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$234.96 - $292.55 $24.9 Million - $31 Million	-105,794 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$221.42 - $260.97 $23.4 Million - $27.6 Million	105,794 New	105,794 $27.6 Million
Q4 2020 Feb 05, 2021	SELL	$207.01 - $276.09 $10.1 Million - $13.5 Million	-48,833 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$255.65 - $303.1 $250,281 - $296,734	-979 Reduced 1.97%	48,833 $13.3 Million
Q2 2020 Aug 06, 2020	BUY	$225.48 - $295.8 $11.2 Million - $14.7 Million	49,812 New	49,812 $14.5 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Todd Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Todd Asset Management LLC with notifications on news.